Reduced-intensity therapy for pediatric lymphoblastic leukemia: impact of residual disease early in remission induction.
Sidhom I, Shaaban K, Youssef SH, Ali N, Gohar S, Rashed WM, Mehanna M, Salem S, Soliman S, Yassin D, Mansour E, Coustan-Smith E, Ribeiro RC, Rivera GK.
Sidhom I, et al. Among authors: gohar s.
Blood. 2021 Jan 7;137(1):20-28. doi: 10.1182/blood.2020007977.
Blood. 2021.
PMID: 33410896
Free PMC article.
Clinical Trial.